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	 Venous	 thrombosis	 represents	 a	 spectrum	 of	
diseases	 that	 includes	 both	 deep	 venous	 thrombosis	
(DVT)	and	pulmonary	embolism1.	Often,	DVT	is	not	
suspected clinically leading to significant diagnostic 
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Background & objectives: Hospitalization for medical-illness is associated with an increased risk of deep 
venous thrombosis (DVT). However, there are no published data from India addressing at this issue. 
We sought to study the risk factor profile and the incidence of DVT among hospitalized medically-ill 
patients, a tertiary care hospital in northern India.
Methods: All adults admitted to the medical wards and intensive care unit with level 1 or 2 mobility over 
a period of two years (July 2006 to July 2008) at the All India Institute of Medical Sciences hospital, New 
Delhi, were prospectively studied. Patients having DVT at admission or an anticipated hospital stay less 
than 48 h were excluded. The presence of clinical risk factors for DVT was recorded and laboratory 
evaluation was done for hypercoagulable state. A routine surveillance venous compression Doppler 
ultrasonography was performed 12 ± 8 days after hospital admission.
Results: Of the 163 patients, 77 (47%) had more than one risk factor for DVT. Five (3%) patients developed 
DVT; none of them had symptomatic DVT. None of these patients received anticoagulation prior to the 
development of DVT. The mean age of those who developed DVT was 40 ± 13 (25-50) yr; two of five were 
male. The incidence rate of DVT was 2.7 per 1000 person-days of hospital stay [95% confidence interval 
(CI): 0.87 to 6.27]. None of the factors was found to be significantly associated with the risk of DVT.
Interpretation & conclusions: In our setting, although many hospitalized medically-ill patients had risk 
factors for DVT, the absolute risk of DVT was low compared to the western population but clearly elevated 
compared to non hospitalized patients. Large studies from India are required to confirm our findings.
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delays.	Venous	thrombosis	results	in	considerable,	but	
potentially	preventable,	morbidity	and	mortality	among	
hospitalized	patients.	Most	of	the	hospitalized	patients	
have	a	high	risk	of	DVT,	and	hospitalization	for	acute	
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medical-illness	 is	known	 to	be	associated	with	about	
eight-fold	increased	risk	of	DVT2.	
	 Because	of	the	high	rate	of	missed	diagnosis,	the	true	
incidence	of	DVT	is	unknown.	There	is	a	lack	of	adequate	
studies	on	the	incidence	of	DVT.	Only	a	few	studies	exist	
published	literature	most	of	which	were	done	on	surgical	
patients.	There	are	little	published	data	available	on	the	
risk	 of	DVT	 among	 hospitalized	medically-ill	 patients.	
Hence, we sought to study the profile of risk factors and 
the	incidence	of	DVT	among	medically-ill	patients	treated	
at	a	tertiary	care	hospital	in	northern	India.
Material & Methods
	 Consecutive	 adults	 aged	 18	 yr	 or	more	 admitted	
to	the	medical	wards	and	intensive	care	unit	with	level	
1	or	2	mobility	over	a	period	of	 two	years	from	July	
2006	to	July	2008	at	the	All	India	Institute	of	Medical	
Sciences	 hospital,	 New	 Delhi,	 were	 prospectively	
included.	 Patients	who	 had	DVT	 at	 admission	 or	 an	
anticipated	hospital	stay	less	than	48	h,	were	excluded.	
The level of immobilization was defined as follows - 
level	1:	total	bed	rest	or	sedentary	patient;	level	2:	level	
1	with	bathroom	privileges;	and	level	3:	 level	2	with	
activity	as	tolerated	by	the	patient.	A	written	informed	
consent	 was	 obtained	 from	 all	 patients	 participating	
in	 the	 study.	 The	 study	 protocol	 was	 reviewed	 and	
approved	by	the	Institute	Ethics	Committee	at	the	All	
India	Institute	of	Medical	Sciences,	New	Delhi
	 The	 data	were	 collected	 on	 demographic	 details,	
primary diagnosis, and specific risk factors for DVT 
using	 a	 pre-designed	 data	 collection	 instrument.	 At	
enrollment,	a	general	physical	examination	 including	
a	 detailed	 examination	 of	 the	 lower	 limbs	 for	 signs	
of	DVT	was	performed	on	all	patients.	In	addition	to	
evaluation	of	clinically	suspected	DVT	or	pulmonary	
thromboembolism	 as	 decided	 by	 the	 treating	
physician,	 a	 routine	 surveillance	 Doppler	 venous	
ultrasonography	 was	 performed	 on	 all	 patients.	 The	
venous	ultrasonography	was	performed	by	one	of	the	
two	consultant	radiologists	(AS	and	AK)	using	Philips	
HDI	5000®	or	Philips	Envisor	HD®	sonographic	units	
(Philips	International	B.V.,	Amsterdam,	Netherlands).	
Examination	was	performed	using	a	7.5-10	MHz	linear	
transducer	with	compression	of	deep	veins	of	the	thigh	
and	calf	in	a	sequential	manner	in	1	to	2	cm	increments	
from the common femoral, superficial femoral, and 
popliteal	veins.	The	lack	of	venous	compressibility	with	
the	 transducer	 held	 transverse	 to	 the	 artery	 and	 vein	
was interpreted as a positive study and was confirmed 
with color flow and pulsed wave Doppler analysis3-5.	
	 It	 was	 planned	 to	 perform	 a	 venous	 ultrasound	
within	24	h	of	admission	and	repeat	it	weekly	for	low-
risk	 patients	 and	 twice-weekly	 for	 high-risk	 patients	
during	the	hospital	stay.	However,	due	to	the	large	patient	
load	on	the	radiology	unit,	the	venous	ultrasounds	were	
performed	 once	 after	 12	 ±	 8	 days	 of	 hospitalization.	
A	 ProC®	 Global	 assay	 (Dade	 Behring,	 Marburg,	
GmbH)	 was	 performed	 on	 all	 patients	 to	 screen	 for	
abnormalities	of	the	protein	C/S	pathway.	Patients	with	
a	normalized	ratio	<	0.7	underwent	further	estimation	of	
protein	C	and	S	and	antithrombin	levels	in	the	plasma.	
Antithrombin	 was	 estimated	 by	 nephelometry	 using	
Turbox®	 antithrombin	 kit	 (Orion	 Diagnostica,	 Espoo,	
Finland);	 the	 lower	 limit	 of	 normal	was	 200	mg/l	 for	
this	 assay.	 Protein	 C	 and	 S	 levels	 were	 estimated	 by	
enzyme-linked	immunosorbent	assay	(ELISA)	using	the	
REAADS®	kit	(Corgenix	Inc.,	Colorado,	USA).	Lower	
limit	of	normal	for	protein	C	was	70	per	cent	and	that	for	
protein	S	was	60	per	cent.	In	addition,	estimation	of	IgM	
and	 IgG	 antiphospholipid	 antibodies	 by	 ELISA	 using	
the	AESKULISA®Phospholipid-Screen-GM	kit	(Aesku	
Diagnostics	GmbH)	was	done	in	all	the	patients.
	 The	incidence	rate	of	DVT	was	calculated	assuming	
a	Poisson	distribution	using	a	statistical	software	package	
(Intercooled	stata	8.0	for	windows,	Stata	Corp.,	College	
Station,	Texas,	USA).	We	compared	the	categorical	data	
between	groups	by	the	Fisher’s	exact	test	and	continuous	
variables	by	the	independent	samples	t-test.	
Results
	 A	total	of	163	patients	contributing	to	1860	person-
days	of	observation	were	studied.	None	of	the	patients	
had	 a	 prior	 history	 of	DVT.	Table	 I	 summarizes	 the	
primary	 medical-illness	 necessitating	 hospitalization	
of	 these	 patients.	All	 patients	 had	 immobilization	 as	
a	 risk	 factor	 for	 DVT.	 Other	 risk	 factors	 that	 were	
recorded	 included	age,	 sex,	duration	of	hospital	 stay,	
smoking,	 alcoholism,	 known	 hypercoagulable	 state,	
malignancy,	haematological	disorder,	surgery,	trauma,	
immobilization,	 intake	 of	 oral	 contraceptive	 pills,	
past	 history	 of	 DVT,	 varicose	 veins,	 central	 venous	
catheterization	and	use	of	mechanical	ventilation.	Of	
the	 163	 patients,	 77	 (47%)	 had	 more	 than	 one	 risk	
factor	 for	 DVT.	 Thirty	 four	 (21%)	 patients	 had	 two	
risk	factors	whereas	three	risk	factors	were	present	in	
27	 (17%)	 patients.	 Thirteen	 (8%)	 patients	 had	 four,	
two had five and one patient had seven risk factors 
for	DVT.	Regarding	critical	care	risk	factors,	 in	 total	
45	 (28%)	 received	 mechanical	 ventilation;	 of	 them	
two	 developed	 DVT.	 Mean	 duration	 of	 mechanical	
ventilation	 in	 patients	 who	 developed	 DVT	 was	
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10.5	days	as	compared	to	6	days	in	patients	who	did	not	
develop	DVT.	On	surveillance,	5	(3%)	of	163	patients	
were	 detected	 to	 have	 DVT	 (all	 proximal);	 none	 of	
them	 had	 symptomatic	DVT.	None	 of	 these	 patients	
received	 anticoagulation	 prior	 to	 the	 development	
of DVT. The demographic profile and risk factors in 
patients	with	and	without	DVT	are	presented	in	Table	
II.	The	mean	age	of	those	who	developed	DVT	was	40	
±	13	(25-50)	yr,	and	two	were	male.	The	incidence	rate	
of	 DVT,	 calculated	 assuming	 a	 Poisson	 distribution,	
was	 2.7	 per	 1000	 person-days	 of	 hospital	 stay	 [95%	
confidence interval (CI): 0.87 to 6.27]. The results of 
laboratory	 evaluation	 for	 hypercoagulable	 state	 are	
presented	in	Table	III.	Hypercoagulability	parameters	
were	 found	 to	 be	 positive	 in	 a	 comparatively	 higher	
percentage	of	patients	with	DVT.	However,	no	factor	
was significantly associated with the risk of DVT.
Discussion
	 It	was	found	that	despite	the	high	proportion	of	risk	
factors	 for	DVT,	 only	 a	 small	 proportion	 of	 patients	
hospitalized	 for	a	medical-illness	developed	DVT.	 In	
earlier	studies	from	western	countries,	the	cumulative	
incidence	 of	 DVT	 among	 medical	 in-patients	 was	
found	to	be	10-20	per	cent,	and	it	was	10-80	per	cent	
among	 critical	 care	 patients6.	 In	 a	 recent	 survey	 of	
hospitals	 from	 32	 countries	worldwide,	about	 42	 per	
cent	 of	 hospitalized	 medical	 patients	 were	 found	 to	
be	at	 risk	 for	venous	 thrombosis7.	 In	 the	same	study,	
a	comparable	proportion	(45%)	of	medical	in-patients	
in	 India	 was	 found	 to	 be	 at	 risk7.	 However,	 we	 did	
not find a statistically significant association between 
any	 of	 the	 clinical	 or	 laboratory	 risk	 factors	 and	 the	
development	of	DVT.	This	is	most	probably	due	to	a	
lack	of	adequate	statistical	power	in	view	of	the	very	
low	number	of	patients	who	developed	DVT.	
	 As	far	as	the	incidence	of	DVT	is	concerned,	most	
of	 the	published	studies	from	India8-17	have	reported	
a	low	incidence	of	DVT	among	hospitalized	patients	
(Table	 IV).	However,	 all	 these	 studies	were	 carried	
out	on	surgical	or	orthopedic	patients,	and	ours	is	the	
first attempt from India to find out the incidence of 
DVT	 in	hospitalized	medically-ill	 patients.	The	 risk	
of	DVT	was	clearly	elevated	in	hospitalized	patients	
Table I. Primary	medical-illness	 necessitating	 hospitalization	 in	
the	study	population
Underlying	disease* Patients	without	
DVT
(n	=	158)
Patients	with	
DVT
(n	=	5)
Infectious	diseases
Pulmonary infection 
GI and liver infection
Genitourinary infection
CNS infection
Systemic infection 
97	(61)
53	(33)
12	(8)
4	(2)
8	(5)
20	(13)
3	(60)
2	(40)
1	(20)
-
-
-
Malignancy 9	(6) -
Chronic	pulmonary	disease 27	(17) -
Cardiac	disease 5	(3) -
Rheumatic	disease	 21	(13) -
Endocrine	disease 4	(2) -
Acute	poisoning 3	(2) 1	(20)
Hematological	disease 2	(1) -
Hepatic	disease 5	(3) -
Neurological	disease 6	(4) -
Others 2	(1) -
Psychiatric	illness - 1	(20)
Data	presented	as	n	(%);	*,	not	mutually	exclusive,	some	patients	
had	multiple	underlying	diseases;	DVT,	deep	venous	thrombosis;	
GI,	gastrointestinal;	CNS,	central	nervous	system
Table II. Demographic profile and risk factors in patients with and 
without	DVT
Risk	factor Patients	without	
DVT
(n	=	158)
Patients	with	
DVT	
(n	=	5)
Age, yr [mean ± SD (range)] 44	±	18	(18-85) 40	±	13	(25-50)
Male	sex 86		(54) 2		(40)
Duration	of	hospital	stay,	days	
[mean ± SD(range)]
21.3	±	12.2	
(1-62)
33.5	±	33.2	
(10-30)
Smoking		 54	(34) 2	(40)
Alcoholism 29	(18) 1	(20)
Known	hypercoagulable		state	 0 0
Malignancy 11	(7) 0
Hematological	disorder 4	(2)	 1	(20)
Surgery 5	(3) 0
Trauma 9	(6) 0
Immobilization 158	(100) 5	(100)
Intake	of	OCPs	 1 0
Past	history	of	DVT 0 0
Varicose	veins	 1 0
Central	venous	catheterization 10	(6) 1	(20)
Mechanical	ventilation	 43	(27) 2	(40)
Data presented as n (%), unless specified; DVT, deep venous 
thrombosis;	OCPs,	oral	contraceptive	pills
Table III. Laboratory	evaluation	for	hypercoagulability	in	patients	
with	and	without	DVT
Laboratory	abnormality Patients	without	
DVT	
(n	=	158)
Patients	with	
DVT	
(n	=	5)
Pro	C®	Global	<	0.7	 53	(33) 1	(20)
IgM	antiphospholipid	antibody-
positive	(>15	IU)
4	(2) 1	(20)
IgG	antiphospholipid	antibody-
positive		
1 0
Antithrombin	<	200	mg/l 4	(2) 0
Protein	C	<	70%	 26	(16) 2	(40)
Protein	S	<	60% 36	(23) 2	(40)
Data	presented	as	n	(%);	DVT,	deep	venous	thrombosis
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in	 our	 study	 compared	 to	 non	 hospitalized	 patients,	
where	risks	were	around	1.5	per	1000	person-years18.	
Our	 study	 results	 are	 in	 contrast	 to	 earlier	 studies	
from	 western	 countries	 and	 reinforce	 the	 repeated	
finding of a low incidence of DVT among surgical 
patients	 in	 India.	 However,	 a	 large	 autopsy-based	
study	from	India	had	found	a	high	prevalence	(16%)	
of	pulmonary	embolism	at	autopsy	in	patients	dying	
of	a	medical-illness17. The significance of this isolated 
autopsy-based	study	in	the	face	of	mounting	evidence	
to	the	contrary	is	unclear.
	 The	 diagnosis	 of	 DVT	 is	 often	 not	 suspected	
clinically,	and	there	is	a	possibility	of	underdiagnosis.	
Therefore,	 venous	 compression	 ultrasonography	 was	
performed	 for	 all	 patients	 irrespective	 of	 the	 clinical	
suspicion.	Doppler	analysis	has	emerged	as	a	sensitive	
and accurate non-invasive test for confirming the 
presence	of	acute	DVT19. Its sensitivity and specificity 
for	 the	 diagnosis	 of	 symptomatic	 proximal	DVT	 are	
97	and	94	per	cent,	 respectively.	Therefore,	although	
ascending	contrast	venography	is	considered	the	gold	
standard	for	the	diagnosis	of	DVT,	the	method	employed	
to	diagnose	DVT	in	the	present	study	is	an	acceptable	
alternative,	and	this	is	unlikely	to	be	the	reason	for	the	
low	incidence	of	DVT	in	the	present	study.	
	 Our	 study	 has	 its	merit	 in	 being	 a	 prospective	
study,	 and	 we	 included	 consecutive	 adults	
hospitalized	for	a	medical-illness	both	to	the	medical	
wards	 and	 the	 ICU.	 Thus,	 our	 study	 population	
faithfully reflects the clinical spectrum of illness 
encountered	by	a	physician	in	a	typical	tertiary	care	
set-up.	Patients	in	a	tertiary	care	set-up	are	likely	to	
be	sicker	and	possibly	are	at	a	comparatively	higher	
risk	 of	DVT	 than	 patients	 treated	 at	 the	 secondary	
care	 level.	 Notwithstanding	 this	 possibility,	
we	 found	 a	 low	 incidence	 of	 DVT	 in	 our	 study	
population.	 The	 limitation	 of	 our	 study	 was	 that	
venous	ultrasonography	could	not	be	performed	as	
planned	due	to	operational	constraints.
	 The	obvious	question	that	arises	now	is	why	only	
a	 small	 number	 of	 our	 patients	 developed	 DVT	 as	
compared	to	the	western	population	despite	apparently	
being	at	comparable	risk.	Our	study	was	not	addressed	
at	 this	 question,	 and	 this	 deserves	 further	 research.	
Inclusion	 of	 symptomatic	 cases	 in	 some	 of	 these	
studies	could	explain	 the	difference	 from	our	 study.	
Another	possible	explanation	is	the	difference	in	the	
genetic	make	up	of	the	population.	Irrespective	of	the	
reason	for	this	difference,	the	results	of	our	study	and	
most	other	Indian	studies	on	surgical	patients	question	
the	advisability	of	routine	use	of	thromboprophylaxis	
in	 hospitalized	 medically-ill	 patients	 which	 is	 now	
considered	the	standard-of-care	in	western	countries.	
Further large studies from India are needed to confirm 
the findings of the present study.
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